These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18506898)

  • 1. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
    Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.
    Hung CH; Lee CM; Wang JH; Hu TH; Chen CH; Lin CY; Lu SN
    Int J Cancer; 2011 May; 128(10):2344-52. PubMed ID: 20669224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.
    Arase Y; Kobayashi M; Suzuki F; Suzuki Y; Kawamura Y; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Kobayashi T
    Hepatology; 2013 Mar; 57(3):964-73. PubMed ID: 22991257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial.
    Yu L; Morishima C; Ioannou GN
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1661-6.e1-3. PubMed ID: 23707779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
    Ohki T; Tateishi R; Sato T; Masuzaki R; Imamura J; Goto T; Yamashiki N; Yoshida H; Kanai F; Kato N; Shiina S; Yoshida H; Kawabe T; Omata M
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):459-64. PubMed ID: 18387499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma.
    Chen W; Tomlinson G; Krahn M; Heathcote J
    J Viral Hepat; 2012 Aug; 19(8):574-80. PubMed ID: 22762142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
    Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
    Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
    Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
    Nkontchou G; Ziol M; Aout M; Lhabadie M; Baazia Y; Mahmoudi A; Roulot D; Ganne-Carrie N; Grando-Lemaire V; Trinchet JC; Gordien E; Vicaut E; Baghad I; Beaugrand M
    J Viral Hepat; 2011 Oct; 18(10):e516-22. PubMed ID: 21914071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.